Amdocs (NASDAQ:DOX) Rating Lowered to Buy at StockNews.com

Amdocs (NASDAQ:DOXGet Free Report) was downgraded by analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a note issued to investors on Wednesday.

Other research analysts have also recently issued research reports about the stock. Barclays dropped their price objective on shares of Amdocs from $113.00 to $111.00 and set an “overweight” rating for the company in a report on Thursday, November 14th. Oppenheimer boosted their price target on shares of Amdocs from $98.00 to $105.00 and gave the stock an “outperform” rating in a report on Wednesday, November 13th. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $101.20.

Get Our Latest Report on Amdocs

Amdocs Trading Up 0.1 %

DOX stock traded up $0.05 during trading on Wednesday, reaching $89.60. 651,746 shares of the stock were exchanged, compared to its average volume of 650,961. The company has a current ratio of 1.16, a quick ratio of 1.20 and a debt-to-equity ratio of 0.22. The business has a 50 day moving average price of $86.04 and a 200-day moving average price of $86.54. Amdocs has a 1 year low of $74.41 and a 1 year high of $94.04. The firm has a market capitalization of $10.11 billion, a price-to-earnings ratio of 20.79, a P/E/G ratio of 1.45 and a beta of 0.71.

Amdocs (NASDAQ:DOXGet Free Report) last issued its earnings results on Tuesday, February 4th. The technology company reported $1.45 EPS for the quarter, missing analysts’ consensus estimates of $1.64 by ($0.19). Amdocs had a return on equity of 18.89% and a net margin of 10.19%. On average, research analysts predict that Amdocs will post 6.21 earnings per share for the current year.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of the stock. Public Employees Retirement System of Ohio acquired a new position in shares of Amdocs in the 4th quarter valued at $3,472,000. Vise Technologies Inc. acquired a new position in shares of Amdocs in the 4th quarter valued at $207,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in shares of Amdocs by 69.2% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 459,830 shares of the technology company’s stock valued at $39,150,000 after buying an additional 188,129 shares in the last quarter. Vident Advisory LLC boosted its holdings in shares of Amdocs by 12.5% in the 4th quarter. Vident Advisory LLC now owns 11,579 shares of the technology company’s stock valued at $986,000 after buying an additional 1,284 shares in the last quarter. Finally, WBI Investments LLC acquired a new position in shares of Amdocs in the 4th quarter valued at $1,227,000. Institutional investors and hedge funds own 92.02% of the company’s stock.

About Amdocs

(Get Free Report)

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.

Featured Articles

Analyst Recommendations for Amdocs (NASDAQ:DOX)

Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.